PALS VF/PVT Algorithm: What Are the Initial Steps and How to Master Them

Understanding what are the initial steps of the VF/PVT PALS algorithm is one of the most critical competencies tested on the Pediatric Advanced Life Support exam and applied in real resuscitation events. Ventricular fibrillation (VF) and pulseless ventricular tachycardia (PVT) are the two shockable rhythms in the pediatric cardiac arrest algorithm, and responding to them quickly and correctly can mean the difference between survival and permanent neurological damage. Every second of delay in defibrillation reduces survival odds significantly.

The PALS VF/PVT algorithm begins with the recognition that the child is unresponsive, not breathing normally, and has no palpable pulse. Once you confirm pulselessness, your team activates the emergency response system simultaneously while beginning high-quality CPR. The algorithm is designed as a loop: two minutes of CPR, rhythm check, shock if shockable, then resume CPR immediately. Deviating from this loop — even briefly — costs time and perfusion pressure that cannot easily be recovered.

Defibrillation is the cornerstone intervention for VF and PVT. The initial shock dose in pediatric patients is 2 J/kg, and if the first shock fails to convert the rhythm, subsequent shocks are escalated to 4 J/kg and then to a maximum of 4–10 J/kg (not to exceed adult doses of 200 J for biphasic devices). This dose escalation strategy distinguishes the pediatric algorithm from adult ACLS and is a common point of confusion on certification exams.

Vascular access and medication administration run in parallel with CPR, not in place of it. Epinephrine is the first-line vasopressor administered every 3–5 minutes throughout the arrest. The dose is 0.01 mg/kg IV/IO (maximum 1 mg per dose). If the rhythm continues to be refractory after at least two shocks, amiodarone 5 mg/kg IV/IO is the preferred antiarrhythmic, with a second dose permissible for refractory or recurrent VF/PVT. Lidocaine is an acceptable alternative if amiodarone is unavailable.

Identifying and treating reversible causes — the Hs and Ts — runs concurrently with every two-minute CPR cycle. Hypovolemia, hypoxia, hydrogen ion (acidosis), hypo/hyperkalemia, and hypothermia make up the Hs, while tension pneumothorax, tamponade, toxins, and thrombosis complete the Ts. In pediatric arrests, hypoxia and hypovolemia are far more common precipitants than primary cardiac arrhythmias, which makes the search for reversible causes especially important in the pediatric population.

For those preparing for their certification exam, understanding the algorithm's timing and sequence is not enough — you must also know the rationale behind each step and how to adapt it to clinical scenarios presented in OSCE-style stations. The pals vf pvt algorithm is woven into multiple exam domains, including rhythm recognition, pharmacology, and team dynamics. Mastering the algorithm in sequence, with correct doses and timing, will pay dividends across several exam questions simultaneously.

This article walks through every phase of the PALS VF/PVT algorithm in detail — from the first pulse check through post-resuscitation care — and pairs each section with practice resources to help you retain what you learn. Whether you are a nurse, respiratory therapist, paramedic, or physician preparing for your PALS renewal, the structured breakdown below will build both your confidence and your clinical accuracy before exam day.

Medication administration during the PALS VF/PVT algorithm demands precision, speed, and a clear understanding of why each drug is given at each point in the sequence. Epinephrine, the cornerstone vasopressor, works by stimulating alpha-1 adrenergic receptors to increase systemic vascular resistance, thereby improving aortic diastolic pressure and coronary perfusion pressure during CPR. Higher coronary perfusion pressure is directly correlated with return of spontaneous circulation (ROSC), which is why timely, correctly dosed epinephrine matters so much. The dose is 0.01 mg/kg IV or IO, with a maximum single dose of 1 mg, repeated every 3–5 minutes throughout the arrest.

Intraosseous (IO) access is an equally acceptable route to intravenous access and should be established immediately if IV access cannot be achieved within 60–90 seconds. IO access delivers medications with pharmacokinetics nearly identical to central venous access because the bone marrow sinusoids drain directly into the central circulation. The tibia (proximal and distal), distal femur, and humeral head are all acceptable IO sites in pediatric patients. Once IO access is established, all PALS medications — epinephrine, amiodarone, and even calcium or sodium bicarbonate when indicated — can be delivered through it.

Amiodarone's mechanism of action involves blocking sodium, potassium, and calcium channels as well as having non-competitive alpha- and beta-adrenergic blocking properties. This broad-spectrum antiarrhythmic effect makes it particularly valuable for VF and PVT that do not convert with initial shocks.

In the PALS algorithm, amiodarone is indicated after the third shock if VF/PVT persists. The 5 mg/kg dose is given as a rapid IV/IO bolus during cardiac arrest — unlike the slow infusion used for hemodynamically stable tachyarrhythmias. A second dose of 5 mg/kg may be given for recurrent or refractory VF/PVT, but the total cumulative dose must remain within safe limits.

Lidocaine serves as an alternative antiarrhythmic when amiodarone is unavailable or contraindicated. The pediatric dose is 1 mg/kg IV/IO bolus. Lidocaine stabilizes cardiac membranes by blocking sodium channels, suppressing abnormal automaticity and re-entry circuits that sustain VF and PVT. While evidence comparing amiodarone and lidocaine in pediatric cardiac arrest is limited, current AHA guidelines favor amiodarone as the first choice based on available adult and pediatric data. Lidocaine should not be overlooked in resource-limited settings.

Calcium and sodium bicarbonate are not routine medications in the VF/PVT algorithm but are indicated for specific reversible causes. Calcium (calcium chloride 20 mg/kg IV/IO) is given for documented or suspected hyperkalemia, hypocalcemia, or calcium-channel blocker toxicity. Sodium bicarbonate (1 mEq/kg IV/IO) may be considered for prolonged arrest with severe metabolic acidosis or hyperkalemia. Both are given during ongoing CPR and should never replace the core sequence of CPR, shock, epinephrine, and amiodarone.

Magnesium sulfate (25–50 mg/kg IV/IO, maximum 2 g) is indicated for torsades de pointes — a specific form of polymorphic ventricular tachycardia associated with prolonged QT intervals. While torsades is uncommon in children, recognizing it on a rhythm strip and knowing the correct treatment is a high-yield exam topic. The treatment differs from standard VF/PVT management because magnesium replaces the conventional antiarrhythmic and is the drug of choice regardless of whether the patient has a pulse or is in cardiac arrest.

Vasopressin is mentioned in some adult ACLS protocols as an alternative to epinephrine, but it is not recommended in current PALS guidelines for pediatric cardiac arrest. This is another distinction between adult ACLS and pediatric PALS that exam candidates must memorize explicitly. Drug dose calculations during a pediatric code are facilitated by the Broselow tape or a length-based resuscitation tape that estimates weight from patient height — a practical tool every PALS provider should be comfortable using before the exam and in clinical practice.

One of the most common errors candidates make when studying the PALS VF/PVT algorithm is treating it as a memorization exercise rather than a clinical reasoning framework. The algorithm is built around physiologic principles — maintaining coronary perfusion pressure, restoring organized electrical activity, and eliminating reversible causes — and understanding these principles allows you to answer novel scenario questions that do not map perfectly onto the algorithm diagram. If you understand why each step exists, you can reason through edge cases that rote memorization cannot handle.

A frequent exam trap involves the timing of epinephrine relative to shocks. Epinephrine is not given before the first or second shock; it enters the algorithm after the second shock (i.e., during the CPR cycle following the second defibrillation attempt). This sequencing reflects the priority of electrical therapy for shockable rhythms — epinephrine's alpha-adrenergic effects improve perfusion pressure but do not directly terminate VF. Giving epinephrine before shocks wastes time that should be spent on definitive electrical therapy. Many test questions exploit this sequencing to catch candidates who merge adult ACLS and pediatric PALS protocols incorrectly.

Another common mistake is confusing the dose escalation pattern. The first shock is 2 J/kg, the second is 4 J/kg, and subsequent shocks are 4–10 J/kg. Some candidates memorize only the first dose and plateau at 2 J/kg for all shocks, which is incorrect. Others over-escalate to 10 J/kg too quickly. The key rule is: after the second shock, the dose range expands to 4–10 J/kg based on clinical judgment, and you should never exceed adult maximum doses for the device being used. Knowing the ceiling dose prevents both under- and over-treatment on the exam.

The Hs and Ts are particularly important in pediatric arrests because the etiology of cardiac arrest in children is almost always respiratory in origin rather than primarily cardiac. Hypoxia — whether from airway obstruction, respiratory failure, bronchospasm, or apnea — is the most common reversible cause of pediatric cardiac arrest. This contrasts sharply with adult arrests, where coronary artery disease and primary arrhythmias predominate.

Exam scenarios may include clues pointing toward a specific reversible cause, such as decreased breath sounds (tension pneumothorax), a history of tricyclic antidepressant ingestion (toxins), or a preceding fever with diarrhea (hypovolemia). Identifying these clues and linking them to targeted treatments demonstrates the clinical reasoning that PALS examiners reward.

Pediatric patients who survive cardiac arrest with VF or PVT have better neurological outcomes than adults with the same rhythms, largely because the underlying myocardium is often structurally normal. However, delayed defibrillation rapidly erodes this advantage. Studies have shown that for every one-minute delay in defibrillation, the likelihood of successful cardioversion decreases by approximately 7–10%. In a hospital setting, the target time from rhythm recognition to first shock should be under 2 minutes. In-hospital teams should keep defibrillators immediately accessible in all resuscitation areas and ensure all PALS-trained staff know the pad/paddle placement technique for both adult and pediatric pads.

Post-resuscitation care decisions also fall within PALS scope and may appear in exam scenarios. Once ROSC is achieved after VF/PVT, the primary concerns are hemodynamic stabilization, targeted temperature management (avoiding fever, maintaining normothermia or controlled hypothermia per institutional protocol), and neurological monitoring. Antiarrhythmic infusions — typically amiodarone at 5–15 mcg/kg/min IV — may be initiated to prevent recurrence of the arrhythmia that caused the arrest. Oxygen should be titrated to maintain SpO2 94–99%, as hyperoxia after ROSC can worsen reperfusion injury and is associated with worse neurological outcomes.

For exam preparation specifically, case-based learning is substantially more effective than reading algorithm diagrams alone. Working through timed practice scenarios — either with a study partner or with a digital quiz platform — forces you to apply knowledge under simulated pressure, which mimics the cognitive demands of both the PALS written exam and the hands-on skills stations. Aim to complete at least 200 practice questions in the cardiac arrest and tachyarrhythmia domains before your exam date, and review every incorrect answer with specific attention to the algorithm step or pharmacology concept that the question tested.

Return of spontaneous circulation (ROSC) is not the end of the resuscitation — it is the beginning of the post-arrest phase, which carries its own management priorities and pitfalls. The period immediately following ROSC is characterized by hemodynamic instability, reperfusion injury, and a high risk of rearrest. Approximately 30–50% of patients who achieve ROSC experience another cardiac arrest within the first hour if not managed aggressively and correctly. Every PALS provider should understand the immediate post-ROSC management priorities as well as the arrest algorithm itself.

The first priority after ROSC is ensuring adequate oxygenation and ventilation without causing hyperoxia or hypocapnia. Both extremes are harmful: hyperoxia generates reactive oxygen species that worsen reperfusion injury, while hypocapnia causes cerebral vasoconstriction and reduces cerebral blood flow at a time when the brain is maximally vulnerable. Target SpO2 of 94–99% and an end-tidal CO2 of 35–45 mmHg in the immediate post-ROSC period. These targets require active titration of the FiO2 and ventilator settings, which is a task for an experienced airway manager familiar with post-arrest physiology.

Hemodynamic support after ROSC focuses on maintaining adequate systolic blood pressure and mean arterial pressure (MAP) for age. Hypotension — defined as systolic BP below the fifth percentile for age — is a powerful predictor of poor neurological outcome after cardiac arrest. A fluid bolus of 10–20 mL/kg isotonic crystalloid is appropriate for ROSC-associated hypotension if the patient is not in cardiogenic shock. If hypotension persists despite fluids, vasoactive infusions (dopamine, epinephrine, or norepinephrine) should be initiated promptly. The choice of agent depends on the suspected mechanism of hypotension and the patient's hemodynamic profile.

Targeted temperature management (TTM) is an area of evolving evidence in pediatric post-arrest care. Current AHA guidelines recommend maintaining post-arrest patients in a normothermic range (36–37.5°C) and actively preventing fever, which is associated with worse neurological outcomes. Therapeutic hypothermia (32–34°C) was previously recommended but is no longer universally advocated for all pediatric patients following the publication of the THAPCA trial, which showed no significant neurological benefit compared to normothermia in children with out-of-hospital cardiac arrest. However, fever prevention remains a firm recommendation across all guidelines.

Neurological prognostication after pediatric VF/PVT arrest should be deferred for at least 72 hours after ROSC, and longer if TTM was used. The pediatric brain has substantially greater neuroplasticity than the adult brain, and apparent neurological deficits in the early post-arrest period often improve significantly over days to weeks. Families should be counseled that early clinical findings — including absent brainstem reflexes and poor responsiveness — are not reliable predictors of long-term neurological outcome in children. Multidisciplinary input from neurology, intensivists, and palliative care specialists is essential before any withdrawal of life-sustaining treatment is considered.

Cardiac catheterization and echocardiography play an important role after ROSC from VF or PVT, particularly when a primary cardiac etiology is suspected. Long QT syndrome, hypertrophic cardiomyopathy, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia (CPVT), and anomalous coronary artery origins are all structural or genetic cardiac conditions that can present as sudden VF or PVT arrest in otherwise healthy children. Identifying these underlying conditions is critical not only for the patient's ongoing management but also for genetic counseling and screening of family members who may be at risk for the same condition.

For candidates using this article as an exam study resource, the post-ROSC section of the PALS course is often underemphasized in informal study sessions but appears consistently on written exams. Questions about post-arrest oxygenation targets, temperature management, hemodynamic goals, and neurological prognostication timing are all fair game. Reviewing the full PALS provider manual sections on systematic post-arrest care alongside focused practice questions — particularly those tied to the cardiac arrest domain — will ensure comprehensive coverage of this high-yield topic area before your certification date.

Building fluency with the PALS VF/PVT algorithm requires more than reading — it requires active recall practice under conditions that simulate the cognitive and time pressure of the real exam. The most effective study strategy combines spaced repetition of core facts (doses, doses, doses), algorithm walk-through practice with a partner playing team leader and team member roles, and high-volume question practice that exposes you to the full range of scenario types the exam uses. Start your preparation at least 2–3 weeks before your exam date to allow time for spaced repetition cycles to consolidate memory.

When practicing algorithm walk-throughs, narrate each step aloud — this forces complete articulation of each decision point rather than vague mental familiarity that collapses under pressure. Start from unresponsiveness, progress through CPR initiation, rhythm identification, shock delivery, medication administration, and Hs and Ts assessment, and finish with the post-ROSC management priorities. Time yourself: the rhythm check and shock delivery pause should take no more than 10 seconds, the medication preparation and administration should happen during the CPR cycle, and the full two-minute CPR loop should feel automatic before your exam date.

For the hands-on skills stations — which are a required component of PALS certification — practice operating the defibrillator your institution uses. Different device models (ZOLL, Lifepak, Philips HeartStart) have different interfaces for selecting energy levels, charging, and delivering shocks.

The exam station evaluators look for confident, purposeful interaction with the equipment, not tentative button-pressing. If your institution uses a specific model, request time with a training unit or simulation device before your exam. Pad placement for pediatric patients — right sternal border below the clavicle, and left lateral chest below the axilla — should be practiced until it is automatic.

Rhythm recognition is a separate skill that many PALS candidates underestimate. VF appears as chaotic, irregular, high-amplitude waveforms with no discernible P waves or QRS complexes. PVT appears as a rapid, wide-complex rhythm (QRS > 0.12 seconds) at rates typically above 150 bpm, without identifiable P waves preceding each QRS. Both rhythms are treated identically with unsynchronized defibrillation.

Common confounders include artifact from movement or lead displacement, which can mimic VF, and supraventricular tachycardia with aberrant conduction, which can mimic PVT. The clinical context — pulse check, patient responsiveness, and preceding events — is essential for differentiating true shockable rhythms from artifact or confounding rhythms.

On the written exam, PALS questions frequently use clinical vignettes that require you to sequence interventions correctly before selecting an answer. A typical question might present a 6-year-old in cardiac arrest with a VF rhythm on the monitor and ask which intervention comes next after the second defibrillation attempt at 4 J/kg.

The correct answer is to resume CPR immediately and establish IV/IO access for epinephrine — not to recheck the rhythm, not to intubate, and not to administer amiodarone yet. Knowing the precise sequencing at each branch point of the algorithm is what separates candidates who pass comfortably from those who borderline-pass or require retesting.

Study resources should include the current AHA PALS Provider Manual (the most authoritative source for exam content), reputable online question banks with detailed answer explanations, and video demonstrations of algorithm steps and skills-station scenarios. High-quality video walkthroughs allow you to observe expert performance of the algorithm — including team communication, defibrillator operation, and seamless CPR transitions — which accelerates skill acquisition more efficiently than text descriptions alone. Supplement these with timed practice tests taken under simulated exam conditions to identify knowledge gaps and build stamina for the written exam format.

Finally, approach your PALS certification not just as a requirement to fulfill but as a genuine investment in your clinical competency. Pediatric cardiac arrest is relatively rare in most clinical settings, which means that when it does occur, providers have less procedural familiarity than they do with more common emergencies.

The PALS algorithm gives you a reliable framework to fall back on under extreme stress, when working memory is taxed and decision speed is critical. Providers who know the algorithm deeply — who have rehearsed it until it is near-automatic — respond more effectively, make fewer errors, and give their patients the best possible chance of survival with intact neurological function.